Judd Berman

1.8k total citations
43 papers, 1.5k citations indexed

About

Judd Berman is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Judd Berman has authored 43 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Judd Berman's work include Chemical Synthesis and Analysis (15 papers), Peptidase Inhibition and Analysis (9 papers) and Receptor Mechanisms and Signaling (8 papers). Judd Berman is often cited by papers focused on Chemical Synthesis and Analysis (15 papers), Peptidase Inhibition and Analysis (9 papers) and Receptor Mechanisms and Signaling (8 papers). Judd Berman collaborates with scholars based in United States, Canada and United Kingdom. Judd Berman's co-authors include Michael Green, Michael H. Tarbit, Jeffrey S. Wiseman, Renae M. Crosby, Tona M. Gilmer, Deirdre K. Luttrell, Michael Luther, Mariano Rodríguez, Timothy J. Lansing and D. Mark Bickett and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Analytical Biochemistry.

In The Last Decade

Judd Berman

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judd Berman United States 20 852 353 246 154 152 43 1.5k
Francesca Zappacosta United States 24 1.5k 1.8× 450 1.3× 203 0.8× 110 0.7× 189 1.2× 45 2.2k
Alexander L. Breeze United Kingdom 27 1.8k 2.2× 228 0.6× 266 1.1× 151 1.0× 119 0.8× 48 2.2k
Chris Dealwis United States 24 968 1.1× 381 1.1× 138 0.6× 46 0.3× 105 0.7× 51 1.7k
Walter H.J. Ward United Kingdom 18 985 1.2× 298 0.8× 264 1.1× 68 0.4× 44 0.3× 33 1.6k
Thomas A. Rano United States 12 1.8k 2.2× 365 1.0× 375 1.5× 212 1.4× 69 0.5× 15 2.4k
Jeffrey Tom United States 16 1.3k 1.5× 284 0.8× 218 0.9× 102 0.7× 44 0.3× 21 1.8k
Wayne J. Brouillette United States 25 1.1k 1.3× 128 0.4× 476 1.9× 48 0.3× 93 0.6× 78 1.6k
Valerio Consalvi Italy 22 1.2k 1.4× 159 0.5× 117 0.5× 142 0.9× 73 0.5× 76 1.9k
Shenping Liu United States 21 1.2k 1.4× 439 1.2× 351 1.4× 169 1.1× 36 0.2× 39 2.1k
Paul Ramage Switzerland 21 971 1.1× 285 0.8× 160 0.7× 73 0.5× 55 0.4× 31 1.6k

Countries citing papers authored by Judd Berman

Since Specialization
Citations

This map shows the geographic impact of Judd Berman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judd Berman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judd Berman more than expected).

Fields of papers citing papers by Judd Berman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judd Berman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judd Berman. The network helps show where Judd Berman may publish in the future.

Co-authorship network of co-authors of Judd Berman

This figure shows the co-authorship network connecting the top 25 collaborators of Judd Berman. A scholar is included among the top collaborators of Judd Berman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judd Berman. Judd Berman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vicens, Quentin, Estefanía Mondragón, F.E. Reyes, et al.. (2018). Structure–Activity Relationship of Flavin Analogues That Target the Flavin Mononucleotide Riboswitch. ACS Chemical Biology. 13(10). 2908–2919. 50 indexed citations
2.
Kaplan, Nachum, Donald E. Awrey, Judd Berman, et al.. (2013). In vitroactivity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics. Journal of Chemotherapy. 25(1). 18–25. 29 indexed citations
3.
Kaplan, Nachum, Monique Albert, Donald E. Awrey, et al.. (2012). Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor. Antimicrobial Agents and Chemotherapy. 56(11). 5865–5874. 92 indexed citations
4.
Sampson, Peter B., Christine J. Picard, Andrew Leeson, et al.. (2009). Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI). Bioorganic & Medicinal Chemistry Letters. 19(18). 5355–5358. 17 indexed citations
5.
Albert, Jeffrey S. & Judd Berman. (2007). Editorial [Hot Topic: Fragment-Based Drug Discovery Approaches (Guest Editors: Jeffrey Albert and Judd Berman)]. Current Topics in Medicinal Chemistry. 7(16). 1543–1543. 1 indexed citations
6.
Bishop, Michael J., Judd Berman, Eric C. Bigham, et al.. (2002). α1-Adrenoceptor Agonists: The Identification of Novel α1A Subtype Selective 2′-Heteroaryl-2-(phenoxymethyl)imidazolines. Bioorganic & Medicinal Chemistry Letters. 12(3). 471–475. 17 indexed citations
7.
Bishop, Michael J., Judd Berman, Eric C. Bigham, et al.. (2001). 2-(Anilinomethyl)imidazolines as α1-adrenoceptor agonists: the identification of α1A subtype selective 2′-carboxylic acid esters and amides. Bioorganic & Medicinal Chemistry Letters. 11(21). 2871–2874. 5 indexed citations
8.
Sherrill, Ronald G., Judd Berman, Dallas K. Croom, et al.. (2001). 1,4-Benzodiazepine Peripheral Cholecystokinin (CCK-A) Receptor Agonists. Bioorganic & Medicinal Chemistry Letters. 11(9). 1145–1148. 22 indexed citations
9.
Shaffer, Joel E., et al.. (1999). Use of “N-in-one” Dosing to Create an in Vivo Pharmacokinetics Database for use in Developing Structure—Pharmacokinetic Relationships. Journal of Pharmaceutical Sciences. 88(3). 313–318. 33 indexed citations
10.
McGeehan, Gerard M., D. Mark Bickett, Jeffrey S. Wiseman, Michael D. Green, & Judd Berman. (1995). [3] Defined substrate mixtures for mapping of proteinase specificities. Methods in enzymology on CD-ROM/Methods in enzymology. 248. 35–46. 6 indexed citations
11.
Kassel, Daniel B., et al.. (1995). HIV-1 Protease Specificity Derived from a Complex Mixture of Synthetic Substrates. Analytical Biochemistry. 228(2). 259–266. 10 indexed citations
12.
Bickett, D. Mark, et al.. (1994). A High Throughput Fluorogenic Substrate for Stromelysin (MMP‐3). Annals of the New York Academy of Sciences. 732(1). 351–355. 12 indexed citations
13.
Luttrell, Deirdre K., Timothy J. Lansing, Renae M. Crosby, et al.. (1994). Involvement of pp60c-src with two major signaling pathways in human breast cancer.. Proceedings of the National Academy of Sciences. 91(1). 83–87. 246 indexed citations
14.
Wypij, Donna M., et al.. (1992). Role of mast cell chymase in the extracellular processing of big-endothelin-1 to endothelin-1 in the perfused rat lung. Biochemical Pharmacology. 43(4). 845–853. 79 indexed citations
15.
Nichols, James S., Judd Berman, Donna M. Wypij, & Jeffrey S. Wiseman. (1991). Evidence Against a Role for Aspartyl Proteases in Intracellular Processing of Big Endothelin. Journal of Cardiovascular Pharmacology. 17. S10–12. 2 indexed citations
16.
Birkett, Ashley J., Dulce Soler, Russell L. Wolz, et al.. (1991). Determination of enzyme specificity in a complex mixture of peptide substrates by N-terminal sequence analysis. Analytical Biochemistry. 196(1). 137–143. 31 indexed citations
17.
Norwood, Daniel L., et al.. (1991). Biomedical applications of high-performance liquid chromatography—mass spectrometry with continuous-flow fast atom bombardment. Journal of Chromatography B Biomedical Sciences and Applications. 562(1-2). 47–58. 17 indexed citations
18.
Chen, Teng‐Man, Bradley L. Ackermann, John E. Coutant, Judd Berman, & John T. Pelton. (1989). Fast atom bombardment mass spectrometric investigation ofin vitro degradation within the disulfide-linked core of atrial natriuretic factor. Journal of Mass Spectrometry. 18(1). 12–19. 1 indexed citations
19.
Hassman, C. Fred, et al.. (1988). Pharmacological profile of 8-amino octanoic acid substituted atrial natriuretic factor analogs. Biochemical and Biophysical Research Communications. 152(3). 1070–1075. 5 indexed citations
20.
Berman, Judd, et al.. (1988). Design and synthesis of metabolically stable atrial natriuretic factor analogs. FEBS Letters. 237(1-2). 76–80. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Zappacosta Breakdown of academic impact, for papers by Alexander L. Breeze Breakdown of academic impact, for papers by Chris Dealwis Breakdown of academic impact, for papers by Walter H.J. Ward Breakdown of academic impact, for papers by Thomas A. Rano Breakdown of academic impact, for papers by Jeffrey Tom Breakdown of academic impact, for papers by Wayne J. Brouillette Breakdown of academic impact, for papers by Valerio Consalvi Breakdown of academic impact, for papers by Shenping Liu Breakdown of academic impact, for papers by Paul Ramage
Rankless by CCL
2026